The risk/benefit equation for therapeutic plasma exchange. Analysis of the rationale for and the safety aspects of therapeutic plasma exchange.
Isbister
J P
JP
Department of Haematology, Royal North Shore Hospital of Sydney, Australia.
D000361:Agammaglobulinemia / Q000209:etiology; D001327:Autoimmune Diseases / Q000503:physiopathology / Q000628:therapy; D001798:Blood Proteins / Q000008:administration & dosage; D001810:Blood Volume; D003657:Decision Making; D004632:Emergency Medical Services; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D007239:Infections / Q000209:etiology; D007258:Informed Consent; D010951:Plasma Exchange / Q000009:adverse effects; D012306:Risk
D001798:Blood Proteins